Li Zheng

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Prognostic Factors

Patient Reported Outcomes

Ejection Fraction

Top Venues

British journal of clinical pharmacology

The Journal of clinical endocrinology and metabolism

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yi He, Ying Jin, Hen Xue, Runhan Liu, Mengyu Zhang, Ruoxi Liao, Maoli Chen, Xueli Zhou, Xueqin He, Min Qin, Kuo Li, Huiqun Zou, Ying Gan, Zhenlei Wang, Li Zheng, Hui Zhong, Ping Fu
Pharmacokinetics and pharmacodynamics of sacubitril/valsartan in peritoneal dialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)
Zhenlei Wang, Xinghai Li, Ying Jin, Runhan Liu, Xiangjie Di, Yi Zhou, Ying Wang, Lei Fan, Yuanwei Chen, Yongsheng Wang, Li Zheng
Safety, Efficacy, and Pharmacokinetics of HP501 in Healthy Volunteers and Hyperuricemic Patients: A Phase I/IIa Study. The Journal of clinical endocrinology and metabolism 107 (6) (2022)
Xiaoyu Li, Ke Cheng, Xinghai Li, Yuwen Zhou, Zhenhua Liu, Hao Zeng, Yuanwei Chen, Xiao Liu, Ying Zhang, Yongsheng Wang, Feng Bi, Li Zheng
Phase I clinical trial of HC-1119: A deuterated form of enzalutamide. International journal of cancer 149 (7) (2021)
Zhenlei Wang, Zhijun Zeng, Lijun Ye, Xiaohong Zhu, Yuwen Pei, Yongsheng Wang, Li Zheng
Impact of target-mediated drug disposition on hetrombopag pharmacokinetics and pharmacodynamics in Chinese healthy subjects and patients with chronic idiopathic thrombocytopenic purpura. British journal of clinical pharmacology (2021)
Xiaoyu Li, Meng Qiu, ShengJun Wang, Hong Zhu, Bi Feng, Li Zheng
A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours. Cancer chemotherapy and pharmacology 85 (3) (2020)